BACKGROUND Angina is common in hypertrophic cardiomyopathy (HCM) and is associated with abnormal myocardial
H ypertrophic cardiomyopathy (HCM) afflicts 1 in 500 of the general population (1) . Chest pain affects up to one-half of patients and is believed to result from impaired myocardial perfusion (2) .
Although it is difficult to treat (3), severe perfusion abnormalities are independently predictive of death (4) and development of heart failure (5).
Several potential mechanisms have been proposed to explain these perfusion abnormalities, including increased oxygen requirements due to hypertrophy, impaired ventricular relaxation, anatomic abnormalities of intramyocardial arterioles, and left ventricular outflow tract (LVOT) obstruction (3, (6) (7) (8) . However, the relative contribution of each factor, and the impact of LVOT obstruction compared with myocardial hypertrophy alone, remains unclear.
Wave intensity analysis (WIA) describes the waves that cause acceleration or deceleration of coronary blood (9) , and it has allowed elucidation of the dominant mechanisms underlying coronary flow in structurally normal hearts (10) and aortic stenosis (11) . Acceleration of coronary flow results from either compression waves originating from the aortic (proximal) end or expansion waves originating from the microcirculatory (distal) end. Separated wave intensity allows separation of the proximal and distal effects, whereas net wave intensity describes the net result of opposing waves during the cardiac cycle.
In the healthy heart, coronary flow is largely governed by 2 waves: the forward compression wave Coronary flow abnormalities are common in HCM, with flow reversal during systole and higher flow velocities during diastole (12) (13) (14) .
The goal of the present study was to elucidate the mechanism of myocardial ischemia and angina in HCM through the combination of coronary WIA and cardiac magnetic resonance (CMR) perfusion.
PATIENTS AND METHODS
Consecutive patients with HCM and an indication for coronary angiography were invited to participate.
Control subjects had a structurally normal heart, atypical chest pain, an indication for coronary catheterization, and angiographically unobstructed coronary arteries. All participants provided written informed consent, and the study was approved by an independent ethics committee.
HCM was defined according to American Heart Association criteria (15) . In the wave intensity analysis (WIA) pattern of patients at rest (top), proximally originating waves are displayed above the axis and distally originating waves below the axis. Using a different scale, the ensemble averages (bottom panel) show the trajectory of pressure (solid line) and flow velocity (dashed line).
In control subjects, the dominant wave is the backward expansion wave (BEW), but in patients with hypertrophic cardiomyopathy (HCM), the backward compression wave (BCW) is dominant. Severe left ventricular outflow tract (LVOT) obstruction produces additional forward waves. BP ¼ blood pressure;
BCW tot ¼ backward compression wave total; FCW ¼ forward compression wave; FCW a ¼ additional forward compression wave; FCW2 ¼ forward compression wave 2; FEW ¼ forward expansion wave; FEW a ¼ additional forward expansion wave.
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A balanced steady-state free precession sequence was used to obtain breath-hold cine images in 3 long-axis planes, followed by a contiguous short-axis stack through the ventricle. Myocardial first-pass perfusion imaging was performed by using a rate 3, parallelaccelerated balanced steady-state free precession sequence (19) . Three short-axis images and an image of the arterial input function were acquired every cardiac cycle for 70 cycles. Initial proton densityweighted images were used for subsequent surface coil intensity correction.
CMR first-pass perfusion was recorded at hyperemia and rest. Adenosine was infused at 140 mg/kg/min by using the same protocol as in the invasive study. At peak hyperemia, a 0.05-mmol/kg bolus of gadolinium contrast (Gadovist, Bayer Schering Pharma AG, Berlin, Germany) was rapidly injected was considered significant.
RESULTS
Baseline characteristics are shown in Raphael et al.
arteries. All control subjects had angiographically normal coronary arteries. CFR was lower in patients with HCM compared with control subjects (1.9 AE 0.8 vs. 2.7 AE 0.9; p ¼ 0.01) due to a higher resting mean coronary flow velocity; there was no significant difference in mean coronary flow velocity during hyperemia. Differences in cardiac cycle timings between patients with HCM and control subjects are shown in Table 2 . Table 1) .
At rest, there was a higher BCW tot and lower FEW in patients with HCM compared with control subjects.
The FCW was significantly lower, but there was no significant difference in the BEW. During hyperemia, there was a significant increase in the size of all waves in both groups. The FCW was smaller and the BCW tot was larger in patients with HCM compared with control subjects (Table 4 ; absolute values, Online Table 1 ). There was no difference in the BEW. The ratio of accelerating/decelerating waves at rest was 
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is squeezed back from the intramyocardial vessels toward the epicardial coronary arteries, and the increased compression of the arterioles results in higher impedances within these vessels.
The lower coronary resistance in HCM during diastole resulted in higher diastolic coronary flow in the present study patients. This finding suggests that despite the adverse remodeling and reduction in vessel density observed in HCM (21), vasodilation of the microcirculation is sufficient to normalize the myocardial perfusion at rest, at the expense of the CFR.
In control subjects, the ratio of the net cumulative wave intensity of the FCW to the BCW was approximately 2:1 ( Table 4) , resulting in acceleration of coronary flow during early systole. In HCM, this ratio was reversed to approximately 1:2, causing deceleration during early systole. The situation was worsened during hyperemia, in which the ratio was reduced to 1:4, and reversal of blood flow direction was even greater.
As the ventricle relaxes, compression of the intramyocardial vessels is relieved, generating a BEW that accelerates coronary flow. In the present HCM cohort, the BCW during ventricular contraction was greater than the BEW during ventricular relaxation, which was the opposite of the pattern seen in control subjects.
Patients with HCM typically have diastolic impairment it is therefore not surprising that division of the present patient cohort according to presence of LVOT obstruction yielded no significant differences between the 2 subgroups.
The relative timing of systole and diastole further disadvantages patients with LVOT obstruction, which prolongs the duration of LV ejection at the expense of the diastolic phase (27) . Despite the favorable reduction in microcirculatory resistance during diastole, the duration of diastolic coronary flow is reduced. Mean coronary resistance was defined as the mean of the instantaneous resistance over the entire cardiac period. Resistance was lowest in HCM patients with LVOT obstruction and highest in control subjects. Abbreviations as in Figure 1 .
The situation is exacerbated at higher heart rates, with an even shorter diastolic time despite increased basal metabolic requirements. Abbreviations as in Tables 1 and 3 . The myocardial perfusion reserve (MPR) was measured using cardiac magnetic resonance imaging and compared with the changes in wave intensity between rest and hyperemia.
There was a significant correlation between the MPR and the proportionate increase in percentage of accelerating waves during hyperemia. HCM ¼ hypertrophic cardiomyopathy.
Raphael et al. There are 3 main mechanisms that result in abnormal myocardial perfusion in hypertrophic cardiomyopathy (HCM) involving waves causing coronary flow acceleration (black arrows) and those leading to deceleration (white arrows; each arrow is in the direction of the underlying wave, rather than the direction of coronary flow). Mechanisms of Myocardial Ischemia in HCM
